Using radioimmunoassay methods, the blood of patients with pancreatic
tumors was screened for circulating polypeptide hormones. This screeni
ng discovered pancreatic polypeptide in abnormally high concentration
in the serum of six of seven patients with adenocarcinomas of the bile
duct. The assay appears to be very sensitive finding excessive residu
al pancreatic polypeptide production after palliative resections. Seru
m pancreatic polypeptide assays warrant evaluation as an aid in the di
agnosis and management of patients with bile duct tumors.